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Abstract
Background: Multiple sclerosis (MS) is often accompanied by optic nerve inflammation. And some patients
experience permanent vision loss. We examined if the grade of optic nerve infiltration and demyelination affects
the severity of clinical signs in an experimental autoimmune encephalomyelitis (EAE) model. The loss of retinal
ganglion cells (RGC) and alterations in glia activity were also investigated.
Methods: C57BL/6 mice were immunized with peptide MOG35-55 in complete Freund’s adjuvant (CFA) and controls
received PBS in CFA. Then 23 days post immunization eyes were prepared for flatmounts and stained with Nissl to
evaluated neuronal density. Clinical EAE symptoms as well as cell infiltration and demyelination in the optic nerve were
examined. Retinal sections were stained with hematoxylin and eosin and silver stain. Immunohistochemistry was used to
label RGCs (Brn-3a), apoptotic cells (caspase 3), macroglia (glial fibrillary acidic protein (GFAP)), microglia (Iba1),
macrophages (F 4/80) and interleukin-6 (IL-6) secretion.
Results: EAE symptoms started at day 8 and peaked at day 15. Cell infiltrations (P = 0.0047) and demyelination (P = 0.0018)
of EAE nerves correlated with the clinical score (r> 0.8). EAE led to a significant loss of RGCs (P< 0.0001). Significantly more
caspase 3+ cells were noted in these animals (P = 0.0222). They showed an increased expression of GFAP (P< 0.0002) and a
higher number of microglial cells (P< 0.0001). Also more macrophages and IL-6 secretion were observed in EAE mice.
Conclusions: MOG immunization leads to optic neuritis and RGC loss. EAE severity is related to the severity of optic nerve
inflammation and demyelination. EAE not only affects activation of apoptotic signals, but also causes a glial response in the
retina.
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Background
Multiple sclerosis (MS) is an autoimmune-mediated neu-
rodegenerative disease with characteristic inflammatory
demyelination in the central nervous system [1]. Patients
with this disease suffer from many disabilities like memory
dysfunction, cognitive deficit and movement disorders.
Studies on patients indicate significant axonal damage
and a decrease of retinal ganglion cells accompanied
with a loss of vision [2-4] and thinning of the retinal
nerve fiber layer. Decreased macular volume can be
seen after a single clinical episode of optic neuritis, which
is correlated with the level of residual visual dysfunction
[5]. The majority of patients recover from this vision
loss after several weeks. But in 40% of these patients vision
loss remains permanent [6,7]. Studies indicate that on the
one hand the loss of vision after an episode of optic
neuritis correlates with death of retinal ganglion cells
(RGCs) [8,9], on the other hand there are some patients
where RGC loss occurs without an episode of optic
neuritis, suggesting that the RGC decrease mediates
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visual loss in this disease [10]. The precise mechanisms
leading to this neurodegeneration remain unknown.
The experimental autoimmune encephalomyelitis (EAE)
model is the most common animal model used for mul-
tiple sclerosis studies [3,6,11,12]. We immunized C57BL/6
mice with myelin oligodendrocyte glycoprotein peptide
(MOG35–55), a widely applied method to induce EAE in
animals [1,5,12,13]. Both MS and EAE are characterized
by inflammation and neurodegeneration in the spinal
cord and the brain [12]. Although, there are some studies
describing the effect of MS and EAE in the optic nerve,
the impact on the retina is still not well understood
[14-16].
In our study we examined optic nerve cell infiltration to
determine if the severity of the optic nerve histopathology
correlates with the clinical EAE score. Additionally, eyes
were evaluated for RGC loss and alterations in micro-
and macroglial activation. Furthermore, we checked for
activated phagocytic microglial cells and interleukin-6
(IL-6) as signs of inflammation. The severity of cell
infiltration and demyelination in the optic nerve strongly
correlated with the severity of clinical disease. This was
accompanied by retinal ganglion cell loss and glia and




Male C57BL/6 mice (8 weeks old; ZVTE, Mainz, Germany)
were housed and maintained under environmentally
controlled conditions in a 12-hour light/dark cycle with
access to food and water ad libitum in the absence of
pathogens. All experiments that involved animal use were
performed in compliance with the ARVO statement for
the Use of Animals in Ophthalmic and Vision Research.
These experiments have been approved by the local
animal care committee.
Induction and evaluation of experimental autoimmune
encephalomyelitis
Mice (n = 9) were injected subcutaneously in the tailpleat
with 100 μg MOG35-55 (MOG) in complete Freund’s
adjuvant (CFA, 550 μg/100 μl, Difco Laboratories, Detroit,
MI, USA). At the same time as immunization and 48
hours post immunization, animals received 200 ng of
pertussis toxin intraperitoneally (Sigma-Aldrich, St Louis,
MO, USA). Control mice (CO; n = 8) received the same
treatment as immunized mice except that MOG was
replaced by PBS.
All animals were examined and scored daily for clinical
signs of EAE [17]. Animals were clinically graded as
follows: 0 = no signs, 1 = loss of tail tonicity, 2 = loss of
tail tonicity and mild paralysis of hindlimbs, 3 = paralysis
of hindlimbs, 4 = hindlimb paralysis and mild paralysis of
forelimbs and 5 = complete paralysis or death.
Cresyl violet staining of flatmounts
Then 23 days post immunization, eyes (n = 8 per group)
were fixed in 4% paraformaldehyde for 1 h and then
prepared as flatmounts. After de- and rehydration in
70% to 100% ethanol, retinal flatmounts were stained
with Nissl stain with 1% cresyl violet (Merck, Darmstadt,
Germany) [6]. Subsequently, all slides were again dehy-
drated in ethanol followed by incubation in xylene,
before flatmounts were mounted with Eukitt (both Merck,
Darmstadt, Germany). Photographs of the central, middle
and peripheral parts of each flatmount arm were taken
with a microscope equipped with a CCD camera (Axio
Imager M1, Zeiss, Oberkochen, Germany) using 400×
magnification (Figure 1A). The Nissl staining allowed
distinction between neuronal cells (>8 μm in diameter,
irregular cell shape and prominent nucleolus), endothelial
cells (longitudinal shape) and glia cells (<8 μm, round
shape) based on their morphology, size and location
(Figure 1B) [6]. Neuronal cells were counted in a blinded
Figure 1 Areas and cell types of interest for data analysis. (A) Representative flatmount preparation showing three areas: central (c), middle
(m) and peripheral (p). Photographs of each area in each arm were taken using an Axio Imager M1 microscope. (B) The pictures were analyzed
using ImageJ software (1: neurons, 2: glia, 3: endothelia). Only neurons were included for further analysis. Scale bar: 10 μm.
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fashion in the three areas of each arm using ImageJ
(Version 1.44, NIH, Bethesda, MD, USA); the other cell
types were excluded from the further analysis.
Histology and morphology of retina crosssections
Hematoxylin and eosin (H&E) staining was performed to
analyze the thickness of the retinal layers. Additionally,
Bielschowsky’s silver impregnation (BSI) was used to
detect deposits and infiltrates in the retina. The eyes of
control and EAE animals were fixed in 4% paraformalde-
hyde and embedded in paraffin (n = 5 to 7 eyes/group).
Retina crosssections (5 μm thick) were cut. After de- and
rehydration in 70% to 100% ethanol, the crosssections
were stained with H&E and BSI [18,19]. Subsequently,
all slides were again dehydrated in ethanol followed by
incubation in xylene before being mounted with Eukitt.
Measurement of retinal layers was conducted as follows.
Pictures of six H&E stained crosssections per eye were
taken with a microscope equipped with a CCD camera
(Axio Imager M1) at 40× magnification. Images were
analyzed with the built-in measuring tool in ZEN 2011
software (V1.0.1.0, Zeiss, Oberkochen, Germany). The
thicknesses of the whole retina (excluding the outer
segments) and the ganglion cell layer (GCL), inner
plexiform layer (IPL), inner nuclear layer (INL), outer
plexiform layer (OPL) and outer nuclear layer (ONL)
were measured for each layer in each picture in three
different areas. Data were collected in Excel and then
imported to Statistica (V10.0; Statsoft, Tulsa, OK, USA)
for statistical analysis.
Immunohistochemistry of retina crosssections
Paraffin-embedded retina crosssections (5 μm thick, n = 5
to 7 eyes/group) were prepared for immunohistochemistry
as follows: sections were deparaffinized and rehydrated.
Antigen retrieval was performed in 10 mM sodiumcitrate
buffer (pH 6.0) containing 0.05% Triton X-100 at 95°C
in a water bath for 30 min. The sections were then
blocked in 10% appropriate serum in 0.1% Triton X-100
in PBS. Six retina crosssections per animals were used
for each staining. Retinal ganglion cells were stained
with Brn-3a (1:100, Santa Cruz, Heidelberg, Germany),
a specific retinal ganglion cell marker. Inactive caspase 3
(1:100, Biozol, Echingen, Germany), an apoptosis protein
marker, was used to stain apoptotic cells. Both were
labeled with the secondary antibody Alexa 555 (1:500,
Invitrogen, Darmstadt, Germany). Macroglial cells were
investigated with an Alexa 488 conjugated glial fibrillary
acidic protein (GFAP) antibody (1:1200, Millipore,
Billerica, MA, USA). Microglial cells were stained with
Iba1 (1:400, Wako Chemicals, Neuss, Germany) followed
by Alexa 555 (1:500, Invitrogen) as the secondary anti-
body. Staining of activated microglial cells was performed
in a double staining experiment using F 4/80 antibody
(1:50, AbDserotec, Düsseldorf, Germany) and Iba1 (1:400,
Wako Chemicals). Appropriate secondary antibodies were
used (Alexa 488, 1:500, Life Technologies Darmstadt,
Germany; Alexa 555, 1:500, Invitrogen). All slides were
mounted with antifade medium containing fluorescent
nuclear stain DAPI (Fluoro-Mount w/DAPI; Dianova). In
general, two photographs were taken from the periphery,
middle and central part of each crosssection with an
AxiocamHRc CCD camera on a Zeiss Imager M1 fluor-
escence microscope using a 40× objective. The digita-
lized images were transferred to Corel PaintShop Photo
Pro (V 13; Corel Corporation, Fremont, CA, USA) and
excerpts (800 × 610 pixels) including the GCL and INL
were cut out.
Using the photographs of the Brn3a and caspase 3
stained sections, RGCs or caspase 3+ cells were counted
in six photographs of six retina crosssections per animal,
as described above, in a masked fashion in the GCL
using ImageJ. The data was collected in Excel and then
imported into Statistica for further analysis.
For the glial fibrillary acidic protein (GFAP) staining,
the same camera settings, including exposure time, were
applied on all images using a Zeiss Imager M1 fluores-
cence microscope equipped with an AxiocamHRc CCD
camera. As described above, six photographs of six retina
crosssections per eye were made and the GFAP channel
was transferred into ImageJ for further analysis [20]. To
automate the data analysis, we used a macro that we wrote
ourselves. First, the image was transformed into greyscale.
After background subtraction (20 pixels) the upper and
Figure 2 Scores used for evaluation of EAE symptoms. Mice
were examined daily using a clinical EAE scoring system ranging from
0 (no signs) to 5 (complete paralysis). The clinical symptoms were
scored for 23 days. Symptoms peaked at day 15 (CO: 0 ± 0, EAE: 2.6 ±
0.3, P< 0.0001) and started to decline at day 17 post immunization. The
abscissa represents the experimental days and the ordinate represents
the severity of clinical symptoms (n = 8 to 9 animals/group). Black=CO,
gray=EAE; *: p<0.05; **: p<0.01; ***: p<0.001. CO, control; EAE,
experimental autoimmune encephalomyelitis.
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lower thresholds were set (lower threshold: 3.5; upper
threshold: 80). Background subtraction and upper and
lower thresholds represent mean values of the manually
analyzed images of both CO and EAE animals. The
percentage of the labeled GFAP+ area and the staining
intensity were measured for each picture using a ImageJ
macro, imported to Excel and transferred to Statistica for
further analysis.
Secretion of interleukin-6 was investigated with an
IL-6 antibody (1:100, Abcam, Cambridge, UK) using FITC
as the secondary antibody (1:500, Abcam). Sections
were co-labeled with GFAP (1:400, Millipore) and Cy3
as the secondary antibody (1:500, Millipore). We
counted the IL-6 positive vesicles in the GCL of the
whole retina crosssections (n = 5 to 6 sections/eye)
with an AxiocamHRc CCD camera on a Zeiss Imager
M1 microscope equipped with a 40× objective. The
data were collected in Excel and then imported into
Statistica for analysis.
Optic nerve histology
Optic nerves were fixed in 4% paraformaldehyde over-
night and then embedded in paraffin. Longitudinal optic
nerve sections, 5 μm thick, were obtained. To investigate
alterations and structural changes, the optic nerve
sections were stained with standard H&E (n = 4 per
group) and luxol fast blue (LFB; n = 5 per group) [3,6].
Subsequently, all slides were dehydrated and embedded
Figure 3 Evaluation of changes in the optic nerve. (A) H&E-stained longitudinal optic nerve sections of EAE animals exhibited signs of
optic neuritis indicated by cell clustering and disorganization (arrowheads) compared to a regular alignment of cells in the CO (arrows). (B)
The infiltration score (from 0 for no infiltration to 4 for massive infiltration) positively correlated with the EAE score (P< 0.0001, r = 0.9824). CO
mice (blue circles) had no clinical symptoms and infiltration while EAE mice (green circles) had both clinical symptoms and infiltration of cell
clustering in the optic nerve (n = 4 eyes/group). (C) Luxol fast blue staining in longitudinal optic nerve sections of EAE animals revealed signs
of demyelination indicated by white areas in the optic nerve (arrowheads). In CO nerves the myelin sheaths were uniformly stained. (D) The
demyelination score (from 0 for no demyelination to 2 for strong demyelination) was positively correlated with the EAE score (P = 0.0053,
r = 0.8328). CO animals displayed no signs of clinical EAE while in contrast all EAE mice had a clinical EAE score as well as mild to severe
demyelination in the optic nerve (n = 5 eyes/group). Scale bars: 50 μm. CO, control; EAE, experimental autoimmune encephalomyelitis; H&E,
hematoxylin and eosin stain.
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using the same dehydration and embedding protocol as
described above for retina crosssections.
Inflammatory cell infiltration in longitudinal sections
of the optic nerves stained with H&E was evaluated
[1-3,13,21]. Three areas of each optic nerve (four sections/
animal) were graded according to a scale from 0 to 4 by
a masked observer: 0 = no infiltration, 1 = mild cellular
infiltration of the optic nerve or optic nerve sheath, 2 =
moderate infiltration, 3 = severe infiltration and 4 = massive
infiltration of the optic nerve parenchyma and nodule
infiltration. The average score for each optic nerve was
used for statistical analysis.
The demyelination grade was evaluated on longitudinal
LFB-stained optic nerve sections [21-23]. Four slices per
animal were used for LFB staining. Three areas of each
optic nerve (four sections/animal) were graded as follows:
0 = no demyelination, 1 = moderate demyelination and
2 = severe demyelination. The average score for each
optic nerve was used for later statistical evaluation.
Statistics
Data are presented as mean ± standard error of the mean
(SEM) unless otherwise noted. Histology data for the two
groups were compared using the two-tailed Student’s
t-test (Statistica). P values below 0.05 were considered
statistically significant.
Results
Immunization with MOG leads to clinical experimental
autoimmune encephalomyelitis
Animals first developed symptoms of clinical EAE, indi-
cated by a loss of tail tonicity, 8 days post immunization
(Figure 2). Between days 15 and 17 (both days: CO: 0 ± 0,
EAE: 2.6 ± 0.3, P< 0.0001) the animals displayed the
strongest clinical EAE symptoms with loss of tail tonicity
and paralysis of the hindlimbs (Figure 2). After day 17
the clinical symptoms of EAE animals started to decline.
But they were significantly increased compared to CO
animals at all points in time starting at 8 days post
immunization (Figure 2).
Inflammation and demyelination in the optic nerve
To assess structural and morphological changes of the
optic nerves, H&E (Figure 3A) and LFB staining (Figure 3C)
were performed 23 days post immunization. While the
cell nuclei of the axonal fibers were regularly lined up
in the optic nerve (ON) of CO mice, they were clustered
in the nerves of EAE animals (Figure 3A). Furthermore,
massive infiltrate deposits were observed throughout
the ON of animals that developed EAE (Figure 3A).
The severity of the infiltrates were significantly higher
in EAE (P = 0.0047) and positively correlated with the
clinical EAE score (r = 0.98, P< 0.0001, r2 = 0.97, y =
1.2905x + 0.1642, Figure 3B).
Figure 4 RGC count in retina flatmounts and retina crosssections. (A) Representative Nissl-stained flatmounts of CO and EAE retinas
reveal a loss of neurons (yellow arrows) in EAE retinas. The white arrows show glia cells and the arrowheads endothelial cells. Scale bar: 20 μm.
(B) Quantification of neurons on retinal flatmounts (n = 8 eyes/group). The number of neurons (P< 0.0001) was significantly reduced in the
EAE group after 23 days. (C) Immunohistochemical staining of CO and EAE retinas with Brn-3a (RGCs, red) and DAPI (nuclei, blue) 23 days post
immunization. The merged picture shows a reduction of Brn-3a+ stained RGCs (arrows) in the GCL of EAE animals. (D) Quantification of Brn-3a+
cells in the retinas of CO and EAE animals (n = 5 to 7 eyes/group). RGC numbers were significantly reduced in the retinas of EAE mice
(CO: 32.5 ± 1.5 cells/mm, EAE: 26.7 ± 1.9 cells/mm, P = 0.0170). Scale bar: 25 μm. *: p<0.05; ***: p<0.001. CO, control; EAE, experimental
autoimmune encephalomyelitis; GCL, ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; RGC, retinal ganglion cell.
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The structure of the ON of CO mice stained with
LFB displayed a uniform staining of the myelin sheaths
and a smooth distribution of the optic nerve fibers
(Figure 3C). The LFB staining of the ON of EAE mice
showed some whitening, indicating a loss of the myelin
sheaths (Figure 3C). The axonal fibers of EAE mice
exhibited a more disorganized, wavy structure (Figure 3C).
The severity of the demyelination was significantly higher
in EAE (P = 0.0018) and was positively correlated with
the clinical EAE score (r = 0.83, P = 0.0053, r2 = 0.69,
y = 0.7719x + 0.258, Figure 3D). Our results indicate
that optic nerve damage is strongly correlated with the se-
verity of clinical EAE.
Ganglion cell loss in experimental autoimmune
encephalomyelitis animals
Neuronal cells of CO and EAE animals, defined as light
purple cells with a dark nucleus and a rough border, were
quantified on Nissl-stained flatmounts (Figure 4A). We
observed a significant loss of neuronal cells in EAE mice
(7,611.9 ± 194.1 cells/mm2) compared to CO (8,763.1 ±
177.5 cells/mm2, P< 0.0001; Figure 4B). Nissl unspecifically
labels all neuronal cell types, like RGC and amacrine
cells, in the GCL of the retina. Therefore, an additional
staining was performed. Retina crosssections were labeled
with the specific RGC marker Brn-3a (Figure 4C). Quanti-
fication of Brn-3a+ cells revealed a significant reduction of
RGCs in EAE animals (CO: 32.5 ± 1.5 cells/mm,EAE:
26.7 ± 1.9 cells/mm, P = 0.0170, Figure 4D). Consequently,
EAE immunization causes to a loss of neuronal cells in
the retina, especially RGCs.
Intact retinal structures after immunization
To investigate if the structure and morphology of the
retina stayed intact after EAE immunization we performed
H&E and silver staining on retina crosssections. We
did not observe structural or morphological changes in
H&E-stained section of EAE or CO animals (Figure 5A).
Quantification of the thickness of the whole retina
revealed no difference between the control (125.5 ± 2.5
μm) and EAE group (126.2 ± 1.6 μm; P = 0.8). Also,
despite the RGC loss (Figure 4B), no decrease in the
thickness of the GCL was noted (CO: 10.3 ± 0.3 μm,
EAE: 11.1 ± 0.3 μm, P = 0.09, Figure 5B). Only apoptosis
of cells occurs in the GCL and there is no destruction
of this layer. Furthermore, no changes in thickness
were noted for the plexiform layers: IPL (CO: 34.1 ±
0.9 μm, EAE: 33.5 ± 0.7 μm, P = 0.5) and OPL (CO:
10.7 ± 0.3 μm, EAE: 10.3 ± 2.2 μm, P = 0.25) (Figure 5B).
The nuclear layers, INL (CO: 25.7 ± 0.6 μm, EAE: 25.7±
0.4 μm, P = 0.98) and ONL (CO: 47.2 ± 0.9 μm, EAE:
46.8 ± 0.7 μm, P = 0.74) also display no alteration in
thickness in EAE animals compared to controls (Figure 5B).
Although immunizing with MOG35-55 led to RGC loss
Figure 5 Evaluation of infiltrates and neuronal plaques in the
retina. (A) H&E-stained retina crosssections of CO (left) and EAE animals
(right, n = 5 to 7 eyes/group). No difference between CO and EAE in
retinal structure and no neuronal tangles and plaques were observed.
(B) Quantification of the retinal layer thickness (n = 5 to 7 eyes/group).
No difference was noted in the thickness of the layers. (C) Bielschowsky’s
silver stain of retina sections of CO and EAE animals (n = 5 to 7 eyes/
group). The retinal structure of EAE animals was not altered compared
to CO and no neuronal plaques were noted. Scale bars: 25 μm. CO,
control; EAE, experimental autoimmune encephalomyelitis; GCL,
ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer;
ONL, outer nuclear layer; OPL, outer plexiform layer; OS, outer segments.
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it did not affect the structure and morphology of the
retina 23 days after immunization, which would be a
sign of retinal remodeling and degeneration.
Increased apoptosis in experimental autoimmune
encephalomyelitismice
In the GCL of both groups, caspase 3+ cells were present
(Figure 6A). Quantification of caspase 3+ cells in the retinal
ganglion cell layer of CO (35.0 ± 1.9 cells/mm) and EAE
(42.2 ± 2.6 cells/mm) mice demonstrated significantly
more caspase 3+ cells in EAE animals at 23 days post
immunization (P = 0.0222, Figure 6B). This implies that
more apoptotic RGCs are present in EAE mice.
Gliosis in experimental autoimmune encephalomyelitis
retina
To investigate the extent of gliosis in the retina of control
and immunized mice, we examined the expression of
GFAP in astrocytes and end-feet of Müller cells on retina
crosssections. These cells become reactive glial cells when
pathological changes like inflammation occur [24,25].
GFAP expression was analyzed for control and immunized
mice to determine whether changes can be noted. Sub-
sequently, 23 days after immunization only discrete GFAP
staining was observed in Müller end-feet and astrocytes
in the nerve fiber layer and GCL of control animals,
while in EAE animals the expression of GFAP reached
into the IPL (Figure 7A). Quantification of the GFAP+
area revealed a significant GFAP increase in EAE animals
(CO: 2.1 ± 0.1, EAE: 2.7 ± 0.1, P< 0.0001, Figure 7B) as
well as a significant increase in the strength of the
fluorescent signal (CO: 0.4 ± 0.02, EAE: 0.5 ± 0.03, P<
0.0033, Figure 7C). This indicates an increased expression
of fibrillary acidic protein accompanied with an activation
of astrocytes triggered by inflammation and apoptosis
of RGCs.
Activation of microglial cells in experimental autoimmune
encephalomyelitis mice
We investigated the microglial responses in the retina
of immunized and control animals as a sign of retinal
inflammation. The microglial cells were analyzed using
a specific antibody against the calcium-binding protein
Iba1, a protein highly expressed in microglial cells [26,27],
on retina crosssections. Significantly more Iba1+microglial
cells were counted in the retinas of EAE animals 23
days after immunization (CO: 6.2 ± 0.5 cells/mm, EAE:
14.8 ± 0.7 cells/mm, P< 0.0001, Figure 7D, F). This could
be a response to an earlier retinal inflammation.
To investigate the functional state of the microglial
cells, a co-labeling of microglial cells with Iba1 and
the receptor binding antibody F 4/80 was performed.
Only a few Iba1 and F 4/80 positive cells were noted
in both groups (CO: 0.44 ± 0.12 cells/mm, EAE: 1.22 ±
0.22 cells/mm, Figure 7E). But significantly more Iba1
and F 4/80+ cells were present in EAE retinas (P =
0.0023, Figure 7G). Consequently, more macrophages
were activated in the retinas of EAE animals compared
to CO.
Increased interleukin-6 expression in experimental
autoimmune encephalomyelitis animals
To examine the role of cytokines, we investigated the
presence of IL-6. Double staining with GFAP revealed that
IL-6 positive vesicles were encapsulated by macroglial
processes (Figure 8A). Significantly more IL-6 positive
vesicles were detected in EAE retinas (8.0 ± 0.8 vesi-
cles/retina) then CO retinas (4.9 ± 0.5 vesicles/retina,
P = 0.0072, Figure 8B). The increased activation of
macroglial cells and the higher production of IL-6 in
EAE retinas point to the conclusion that inflammatory
processes in the eye play a role during EAE.
Figure 6 Apoptosis in retina crosssections. (A) Immunohistochemical staining of CO and EAE retinas with caspase 3+ (apoptosis protein, red)
and DAPI (nuclei, blue) 23 days post immunization. In the merged image more caspase 3+ cells (arrows) are visible in the GCL of EAE animals.
(B) Mean cell count of caspase 3+ cells in the GCL of the retinas of CO and EAE animals at 23 days (n = 5 to 7 eyes/group). More caspase 3+ cells
were noted in the retinas of EAE animals (CO: 35.0 ± 1.9 cells/mm, EAE: 42.2 ± 2.6 cells/mm, P = 0.0222). Scale bar: 25 μm. *: p<0.05. CO, control;
EAE, experimental autoimmune encephalomyelitis; GCL, ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer.
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Figure 7 Macroglial and microglial changes in EAE retinas. (A) Representative images of GFAP-stained CO and EAE retinas. The GFAP+ signal
was only present in the Müller cell end-feet of CO animals (arrowheads) while it stretched into the IPL of EAE animals (arrows). (B) Quantification
of the GFAP+ area (n = 5 to 7 eyes/group). EAE animals expressed significantly more GFAP+ protein compared to CO animals (P< 0.0001). (C)
Quantification of fluorescence signal. EAE animals had significantly more GFAP+ signal than CO animals (P = 0.0033). (D) Iba1 staining of CO and
EAE retinas. Iba1+ cells were predominantly located in the IPL of CO and EAE animals, but were more abundant in EAE animals. (E) Iba1 and F4/
80 double staining of retina sections. Only a few microglial cells (Iba1, red) were also activated as macrophages in both groups (arrows). (F) Mean
number of Iba1+ cells of retina crosssections (n = 5 to 7 eyes/group). More Iba1+ cells were located in the retinas of EAE animals (CO: 6.2 ± 0.5
cells/mm, EAE: 14.8 ± 0.7 cells/mm, P< 0.0001). (G) Statistical analysis showed significantly more Iba1 and F 4/80 co-labeled cells in EAE retinas
(CO: 0.44 ± 0.12 cells/mm, EAE: 1.22 ± 0.22 cells/mm, P = 0.0023).Scale bars: 25 μm. **: p<0.01; ***: p<0.001. CO, control; EAE, experimental
autoimmune encephalomyelitis; GCL, ganglion cell layer; GFAP, glial fibrillary acidic protein; INL, inner nuclear layer; IPL, inner plexiform layer.
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Discussion
In this study we investigated the effects of EAE in the
optic nerve as well as in the retina. We noted that the
grade of clinical EAE determined the strength of optic
neuritis. This neuritis led to an RGC loss in the retina.
As a consequence of this loss, inflammatory processes
were activated.
Optic neuritis in experimental autoimmune
encephalomyelitis animals
Immunization with MOG35-55 leads to typical signs of
optic nerve inflammation like cell clustering, disruption of
the axon fiber organization and demyelination [1-3,6,13].
We discovered that demyelination and infiltration of
the optic nerve of EAE mice strongly correlated with
the severity of the clinical disease score (Figure 3). To
our knowledge this is the first time that this relation
between clinical diagnosis and cellular response in the
optic nerve has been reported for this MOG EAE
model. Interestingly, we also noted a remission of the
clinical symptoms 17 days post immunization. This in-
dicates cessation of inflammation activity and a possible
restoration of the myelin sheaths. Indeed, in models of
multiple sclerosis a complex process becomes activated.
Macroglial and microglial cells are recruited during the
demyelination processes to remove damaged myelin. This
myelin clearing is crucial in stopping the inflammation
and starting the remyelination process in the central
nervous system, especially in the early disease stages
[28-30]. But this process becomes less effective in later
disease stages and leads to scar-like processes like
building of plaques around the axons [31]. Additionally,
T cells are activated in multiple sclerosis and are known
to secrete cytokines such as TNF-α and IFN-γ [31,32].
T cells and microglial cells are activated and play a
major role in the demyelination of the optic nerve [11].
We assume that the demyelination and scarring process
noted in our study as well as the secretion of cytokines
leads to severe damage of the RGC axons.
Apoptosis of retinal ganglion cells
Axonal damage often results in axonal degeneration and
permanent loss of the cell body by apoptosis. In optic
nerve crush or optic nerve transection models, damaging
the optic nerve leads to a rapidly induced stress response
in RGCs that finally results in apoptosis of the neurons
[33-35]. In our study, immunization with MOG35-55 led
to significant RGC loss (P< 0.0001, Figure 4) through
apoptosis (P = 0.0222, Figure 6). The MOG EAE model
probably has a later onset of apoptosis, compared to other
EAE mouse models [2,3]. This may either indicate that
different antigens induce a different strength or phenotype
of inflammation responses or that different mouse strains
have different levels of resistance to RGC loss based on
their genetic background. It has been demonstrated
that the mouse strain significantly influences the starting
point of RGC loss in an optic nerve crush model [36].
This could also affect the onset of EAE.
Changes in retinal layers
No difference in the thicknesses of the retina layers were
observed between control and EAE animals (Figure 5).
In recent years, optical coherence tomography (OCT) has
become a common method for non-invasively observing
and investigating retinal morphology in rodents [37-39].
Although the major layers of the retina can be identified
using OCT, there are challenges in applying this method
in rodents. It is rather difficult to visualize and monitor
changes in the nerve fiber layer of a retina because of its
thin and fine structure, especially since all commercially
available systems today were designed for human eyes.
Therefore, we did not use OCT to analyze the retinal
structure. Instead, we performed H&E staining to quantify
the thickness of the retinal layers (Figure 5B).
Glia cell and cytokine response
In a previous study, the number of RGCs in eyes with
severe inflammation was significantly lower than the num-
ber of RGCs in eyes with mild inflammation [40]. This
Figure 8 Interleukin-6 secretion in the retina. (A) Sections of CO and EAE mice were double stained with IL-6 (green) and GFAP (red). The
merged image shows IL-6 positive vesicles encapsulated by macroglial (GFAP) processes in CO and EAE animals. Scale bar: 20 μm. (B) Significantly
more IL-6 positive vesicles were noted in EAE retinas (8.0 ± 0.8 vesicles/retina) compared to CO (4.9 ± 0.5 vesicles/retina, P = 0.0072). **: p<0.01; CO,
control; EAE, experimental autoimmune encephalomyelitis; GCL, ganglion cell layer; GFAP, glial fibrillary acidic protein; IL-6, interleukin-6.
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confirms that optic neuritis is not merely an inflammatory
condition, but also involves significant neurodegeneration
mechanisms. Our results indicate that, as a consequence
of optic nerve axon damage and apoptosis of RGCs, the
macroglia becomes activated (Figure 7A,B,C). For other
retinal diseases, like age-related macular degeneration,
diabetic retinopathy or glaucoma, macroglial activation
after neuronal apoptosis, especially of RGCs, has been
described [41-43]. The common pathway in those diseases
seems to be the expression of neurotoxic molecules like
interleukins by astrocytes and Müller glia, which lead to
an inflammatory RGC loss [41-44]. The occurrence of
inflammatory processes in the retina caused by EAE is
supported by the presence of higher levels of IL-6
closely associated with GFAP in EAE animals in our
study (Figure 8). We assume that these mechanisms are
also triggered in the EAE animal model.
Additionally, due to an inflammatory event or cellular
stress, microglial cells are rapidly activated and start to
migrate to the location of the event. This has been
described for neuronal injuries, ischemia, metabolic as
well as hereditary retinopathies and photoreceptor degen-
eration [45-48]. After neuronal injury, the microglia is
activated and releases pro inflammatory substances like
TNF-α and interleukins. We noted significantly more
microglial cells in EAE retinas (P< 0.0001, Figure 7D, E).
We assume that the activation of the microglia (Figure 7E
and G) is a direct response to RGC degeneration. We
cannot rule out that other mechanisms lead to an
increase of glial responses in the retina. The disruption
of the blood–brain barrier is a fundamental event in
the pathogenesis of symptoms of primary central ner-
vous demyelination such as EAE [49,50]. Furthermore,
this disruption leads to inflammatory processes in an
experimental autoimmune uveitis model [51,52]. This
might also be the case in EAE. In age-related macular
degeneration, macrophages are present during the early
stages of the disease and can be directly associated with
RGC loss due to phagocytosis of the cell deposits [53].
In our study, we detected few macrophages in EAE and
control animals. However, we noted significantly more
macrophages in EAE mice. Future studies are needed to
investigate if higher macrophage activation is observed
at earlier points in time.
Conclusion
Immunization with MOG35-55 caused clinical EAE symp-
toms in mice. For the first time, we described a strong
correlation between the severity of optic nerve damage
with the grade of clinical EAE symptoms. Also, the
structure of the retina was still intact, we noted a signifi-
cant RGC loss and an activation of macro- and microglial
cells in the retina. At this late point in time, few microglial
cells were activated as macrophages, probably due to the
apoptosis of the RGCs. The inflammation was presumably
triggered by macroglial secretion of interleukin-6. Based
on our findings, optic neuritis in EAE can be described
as a disease of three continuous mechanisms. First, EAE
starts as an autoimmune disease by causing neuroinflam-
matory responses against the myelin sheaths. This results
in demyelination and inflammation in the optic nerve.
In the second phase, it continues as a neurodegenerative
disease noticeable by apoptosis of RGCs due to demyelin-
ation of the axons. These two steps have already been
suggested and discussed by others [3]. We hypothesize
that this leads to the third step. The apoptosis of RGCs
induces to an activation of inflammatory processes in the
retina. These include the production of IL-6, the activation
of astrocytes and microglial cells and gliosis.
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